In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
After netting $19mm from three investors last month, Spectrum Pharmaceuticals (urology and oncology) has now netted $9.5mm, this time through a registered direct offering to two existing investors. The company sold 1.7mm common shares at $5.83 (an 11% premium) and also issued 90-day warrants to buy 857k shares at the same price. Rodman & Renshaw was the placement agent.
Private Investment in Public Equity
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?